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The current study was performed to analyse the potential existence and struc-
ture of a GHRH-transporting tuberoinfundibular system in the rat median emi-
nence. The immunocytochemical analysis using anti-GHRH revealed an intense
immunoreaction in the ependimary cells, tanycytes, at the level of the floor of
the infundibular recess forming part of the median eminence. The basal pro-
cesses of these cells course towards the external layer of the median eminence
and reach the growth hormone-releasing hormone (GHRH) fibres of the tubero-
infundibular tract and this reaction was increased after intraventricular treat-
ment with colchicine. Thus, these observations suggest the existence of a sec-
ond or alternative cerebrospinal fluid-mediated route of GHRH transport to the
median eminence and implicate the involvement of tanycytes in the regulation
of this novel transport system.
key words: hypothalamus, neuropeptides, ependimary cells,
immunocytochemistry, colchicine
INTRODUCTION
Tanycytes may serve a neuroendocrine transport
function based on their specialised structures, which
include apical microvilli on the ventricular surface and
long basal processes that terminate in blood vessels or
in the glia limitants. Although the precise mechanisms
by which tanycytes modulate hypothalamic secretory
axons have not yet been elucidated, tanycytes are be-
lieved to possess guiding functions for hypothalamic
axons and to be involved in transport mechanisms
between the ventricle and blood vessels of the portal
system [69]. Furthermore, tanycytes in the arcuate
nucleus and median eminence release trophic factors
that regulate hormone secretion by hypothalamic neu-
rones [25]. Supporting this idea, transected axons of
adult hypothalamo-neurohypophyseal neurones regen-
erate along tanycytic processes [14].
Recently, in several animal species, biologically
relevant proteins have been detected in tanycytes
by immunohistochemistry or in situ hybridisation,
including glutamate transporters GLT-1 and GLAST
[3], a-MSH [15], glucose transporter-1 [24], aqua-
porin-9 [21], type 2 iodothyronine deiodinase [22],
insulin-like growth factor binding protein-2 [9], con-
nective tissue growth factor [36], and several recep-
tors for somatostatin [29], GABA [51], glutamate [34,
65], activin type I [52], insulin growth factor I [11,
26], erbB3 and erbB4 [64].
Given that receptors for different mediators of pi-
tuitary growth hormone (GH) secretion, such as GHRH
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(growth-hormone releasing hormone), somatostatin
and  IGF-I, have been localised to the tanycytes of the
median eminence [2, 11, 26, 29], it is reasonable to
hypothesise that tanycytes may play a role in the regu-
lation of GH secretion. Although several publications
demonstrate the presence of receptors for regulatory
peptides in tanycytes, the immunohistochemical anal-
yses of these peptides in tanycytes have received much
less study. Thus, we were prompted to perform the
current investigation to analyse the GHRH-transport-
ing tuberoinfundibular system in the rat median emi-
nence and its different components, particularly the
tanycytes and ependimary cells.
MATERIAL AND METHODS
Maintenance and use of animals
Twenty Sprague-Dawley rats (10 of each sex) were
used for this study. Five of each sex were injected in-
traventricularly (lateral ventricle) with 90 mg of colchi-
cine dissolved in 15 ml of saline. The remaining animals
(5 of each sex) were used as controls and received in-
traventricular injections with 15 ml of saline (lateral ven-
tricle) under ketamine anaesthesia, according to the
established standards of Pellegrino and Cushman [48].
Animals were handled according to the guidelines of
the European Communities Council directive (86/609/
/EEC) and current Spanish legislation for the use and
care of laboratory animals (BOE 67/8509-12,1998).
Generation of anti-GHRH antibodies
To obtain the primary antibodies against rat
GHRH, rat GHRH (amino acids 1–43) was conjugat-
ed to bovine thyroglobulin using the coupling re-
agent carbodiimide. This complex, containing 1.2 mg
of rat GHRH, was emulsified with 4 mg of complete
Freund adjuvant and 4 mg of dried mycobacterium
tuberculosis bacilli and injected subcutaneously in
adult male rabbits. Each animal also received 0.5 ml
of pertussis vaccine with the primary immunisation.
Booster injections were given at fortnightly intervals.
The specificity of the serum was tested against pan-
creatic polypeptide, insulin, gastrin, glucagon, so-
matostatin, arginine-vasopressin, luteinising hor-
mone-releasing hormone, cholecystokinin, b-endor-
phin, secretin and gastrin inhibitory peptide. Based
on radioimmunoassay, the cross reaction was 100%
for rat GHRH (amino acids 1–43), 0.04% for human
GHRH (aa 1–44 isoform) and 0.037% for human
GHRH (aa 1–29 isoform). Thus, all results indicate
that the anti-serum is highly specific for rat GHRH,
as was observed by Fernández et al. [23].
Preparation of histological sections and immun-
ostaining
Twenty-four hours post-treatment, the animals
were sacrificed. After removal, the brains were fixed
in Bouin-Hollande fluid for 5 days and then embed-
ded in paraffin. Serial frontal sections (5 mm) were
made and processed by the PAP enzymatic method
with rabbit serum anti- rat GHRH (dilution 1:1000),
swine serum anti-rabbit immunoglobulin (Dako
z-196, dilution 1:100) and PAP complex (Dako z-113,
dilution 1:200). Saline tris 0.05M (pH: 7.4 with 8%
NaCl) was used for the dilutions and washes. Pre-
absorption tests with rat GHRH and human GHRH
and substitution tests of the primary serum with
normal rabbit serum were performed. After either
the substitution test or preabsorption with rat GHRH,
the immunoreaction was completely abolished.
Morphometric analysis of GHRH immunostaining
The preparations obtained were studied using
a Zeiss-axiophot microscope. The number of GHRH-
-immunoreactive endings contacting with the third
ventricle was calculated by analysing 25 serial sec-
tions per animal (each 25 mm) in the transitional cran-
io-caudal zone at the level of the infundibular recess
(125 sections per sex and group).
In order to determine the number of GHRH-im-
munoreactive tanycytes (only tanycytes in which the
cell nuclei was apparent were scored), we studied 25
sections of the median eminence in the cranio-cau-
dal transitional zone [21] (each 50 mm, mean diame-
ter of cell nuclei: 6.74 mm), per animal. The values
obtained are shown in Table 1. Table 2 shows the val-
ues obtained in the count of GHRH-reactive tanycytes
after applying the correction factor (CF: 0.88) accord-
ing to the Abercrombie [1] formula: Section thickness/
/Object length + Section thickness. For both the pa-
rameters considered, we analysed statistical values per
section and per animal (expressed as the arithmetical
mean ± the standard deviation).
Table 1. Mean values (±SD) of morphometric analysis of
anti-GHRH immunoreactive tanycytes
Group Sex Tanycyte/slide Tanycyte/animal
Control Males 2.21 ± 1.87 25.61 ± 7.62
Females 1.86 ± 0.84 24.62 ± 6.39
Colchicine Males 8.75 ± 3.18* 126.30 ± 20.16*
Females 6.94 ± 3.25* 118.57 ± 18.37*
*p < 0.01
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Calculation of the GHRH-immunoreactive tanycytes
was performed with an Apple digital planimeter con-
nected to an RCA video system. The values obtained
were compared statistically using the ANOVA-test.
Values of p < 0.05 were considered as significant.
RESULTS
The hypothalamus of control and colchicine-treat-
ed rats contained GHRH-reactive neurones situated
in the arcuate nucleus, in the lateral basal hypothal-
amus and in the perifornical region. GHRH-immu-
noreactive fibres were noted in the external layer of
the median eminence (Fig. 1, 2), forming part of the
tuberoinfundibular system.
Most anti-GHRH reactive neurones were spindle-
shaped or round, with two prominent prolongations
(Fig. 3). Occasionally, in the arcuate nucleus, bipolar
cells were observed; they exhibited a medial prolon-
gation directed towards the lumen of the third ven-
tricle, and another lateral one projecting towards
other zones, possibly to the GHRH-tuberoinfundib-
Figure 1. Frontal section of the cranial region of the median emi-
nence of an untreated control animal demonstrating GHRH-immu-
noreactive fibres located in the external layer of the median emi-
nence (thin arrows) and somata of GHRH-immunoreactive tany-
cytes (arrows). Bar = 50 µm.
Figure 2. Frontal section of the median eminence at the cranio-
caudal transition level of a colchicine-treated animal displaying
the fibres of the tuberoinfundibular system in its external zone
(thin arrows) and tanycytes (head arrows) al the level of the floor
of the infundibular recess that are immunoreactive with anti-
-GHRH (III V — third ventricle). Bar = 50 µm.
Figure 4. Anti-GHRH immunoreactive fibres (arrows) that reach
the lateral wall of the third ventricle (III V) and penetrate between
ependymary cells. Image obtained from the anterior caudal por-
tion of the median eminence of a colchicine-treated animal.
Bar = 50 µm.
Table 2. Mean values (±SD) morphometric analysis of
anti-GHRH immunoreactive tanycytes with Abercrombie’s
correction factor (1)
Group Sex Tanycytes/animal
Control Males 22.57 ± 6.71
Females 21.70 ± 5.63
Colchicine Males 111.30 ± 17.77
Females 104.49 ± 19.71
Figure 3. GHRH-reactive neurone located in the lateral basal hy-
pothalamus of a colchicine-treated rat. Bar = 10 µm.
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ular system. In the colchicine-treated animals, GHRH
immunoreactive endings were also seen in the later-
al wall of the third ventricle at the level of the arcu-
ate nucleus. After passing between two ependimary
non-immunoreactive cells, these fibres contacted the
lumen of the third ventricle (Fig. 4).
Analysis of anti-GHRH staining of the median
eminence from both animal groups revealed specia-
lised ependimary cells, whose morphology suggest-
ed that they were GHRH-containing tanycytes (Fig.
1, 2, 5). These cells were localised in the floor of the
infundibular recess at the level of the cranial region
and the transition of the cranial to the caudal re-
gions of the median eminence, as described by Rod-
riguez et al. [56]. Moreover, these cells continued
until the beginning of the hypophyseal stalk. Cau-
dally to these immunoreactive cells, neither fibres
nor reactive ependimary cells were observed. In the
untreated control animals, only isolated tanycyte
somata were seen and these stained weakly (Fig. 1).
As expected, in the animals treated with colchicine,
the anti-GHRH immunoreaction was stronger than
in the control animals. Many basal processes were
observed (Fig. 2, 5), together with an increase in the
number of the GHRH-immunoreactive tanycytes
when compared to the untreated control animals
(p < 0.01) (Table 1, 2). Colchicine treatment appeared
to slightly alter the shape of the immunoreactive
tanycytes, although they were typically well-stained
and visibly projected from the floor of the infundib-
ular recess to the external layer of the median emi-
nence (Fig. 1–3), intermingling with other immunore-
active fibres possibly belonging to the tuberoin-
fundibular system. The appearance of reactive tany-
cytes in the dorsal and angular walls of the infundib-
ular recess was very rare.
These findings were similar for both male and
female rats. No differences in the morphological and
immunohistochemical features between the sexes
were observed. Interestingly, anti-GHRH immunore-
active tanycytes were more numerous in males than
in females (Table 1, 2), although the differences were
not statistically significant.
DISCUSSION
Since the discovery and synthesis of GHRH [27,
54], many studies have focused on the identifica-
tion of GHRH-producing neurones and their intra-
hypothalamic location in teleost fish [45, 46], rats
[6, 9, 16, 32, 38, 41], cats [10], primates [4, 5, 37]
and human [7, 8, 39, 49, 63]. Although the projec-
tions of the GHRH-tuberoinfundibular system in these
various species have been documented, none of these
studies has described the tanycyte system as one
containing GHRH-reactive cells.
Several reasons may explain why the present find-
ings have been overlooked or not detected by previ-
ous studies. First, some of the earlier studies were
performed in humans or in animal species other than
the rat and, thus, anatomical or technical differenc-
es may have obscured the detection of GHRH-reac-
tive tanyctes in these other systems. In the published
studies of the rat, differences in methodology may
explain the failure of other researchers to detect
GHRH staining in tanycytes. Some investigations have
relied on anti-human or porcine GHRH serum [35,
Figure 5. Magnification anti-GHRH staining of the somata of the tanycytes (arrow bead) and their basal processes (thin arrows)
(III V — third ventricle). Bar = 50 µm.
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41]; others used vibratome sections to analyse the
reactive neuronal somata and fibres of the tubero-
infundibular system [18, 20, 31, 66], while others
analysed the co-expression of GHRH with other sub-
stances [16, 17, 40, 44, 53]. Vibratome preparations
may have masked these results because the tany-
cyte processes would have been hidden behind the
immunoreactive fibres. None of the published stud-
ies considered the possibility that tanycytes contain
immunoreactive GHRH and none was conducted with
paraffin sections immunostained for GHRH after
colchicine treatment as in the current study.
As a classic inhibitor of neuronal secretion and
re-uptake, colchicine administration has been used
extensively as a tool to facilitate detection of low-
abundance peptides or hormones in different cellu-
lar types, which under normal conditions might not
display sufficient immunoreactivity for detection.
Thus, colchicine is commonly used to increase the
intensity of the immunoreaction, especially in the
studies of the central nervous system [42, 58, 59,
61]. In our studies, we did not observe any evidence
of an inflammatory reaction in response to treat-
ment with colchicine, as described by Hasson and
Norstrom [30] and Norstrom et al. [43] and, thus,
can exclude the possibility that our findings regard-
ing GHRH-staining in tanycytes reflect a secondary
effect of this substance. This fact is also confirmed
by the detection of anti-GHRH immunoreactive-tany-
cytes in the untreated animals, further dismissing
any doubts that our observations represent artefacts
resulting from colchicine administration at the level
of the lateral ventricle.
The increased immunoreactivity for GHRH after
treatment with colchicine was most likely the result
of the slowing of intracellular transport and inhibi-
tion of exocytosis, similar to what has been described
by our laboratory in neuronal and pituitary cells [12,
13, 47, 58, 59] and by other authors in the median
eminence [60, 62, 68].
Although the transport through the tanycytes of
the median eminence has been observed by several
researchers [55, 57, 63], no clear evidence exists that
this actually occurs. In fact, the possibility of this
transport system has been refuted by several publi-
cations [50, 67). The release of GHRH toward the
CSF is possible, although a detailed characterisation
of the peptide in the CSF of the rat similar to that
described in humans [33] would be required to cor-
roborate such a hypothesis.
Guldner and Wolff [28] have described ultrastruc-
tural images of synapse-like connections between
axonal profiles and tanycyte processes and studying
the neuronal regulation of GH secretion, Daikoku et
al. [19] have reported similar images, although these
connections were observed in unstained sections.
Given that expression of IGF-I binding protein-2 [11],
receptors for IGF-I [2, 11, 26] and somatostatin [29]
have been observed in the luminal membrane of
tanycytes of the median eminence, the immunode-
tection of GHRH in the tanycytes reported by the
present study suggests that tanycytes of median
eminence may participate in the regulation of GH
secretion.
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